21 results
Thumbnail

D2.415 - Application of magnetic particle chemiluminescence technology to detect sensitization in patients in Guangzhou, China: a study base on real-world medical data

Thumbnail

D2.419 - Quality of life and measures of well-being of Canadian patients with HAE C1-INH based on data from the 2020 and 2024 national surveys

Thumbnail

D2.420 - Sensitization Profile of Lipocalins: sIgE Analysis in a Large Cohort of Patients with Suspected Allergies

Thumbnail

D2.413 - Association of sensitization to fur animal allergens and Bet v 1 in the Russian population

Thumbnail

D2.414 - Trends in the prevalence of asthma in Korean children: a population-based study from 1995 to 2022

Thumbnail

D2.416 - Online Education Significantly Improves Physicians’ Knowledge of Novel Long-Term Prophylaxis Therapies for Hereditary Angioedema

Thumbnail

D2.417 - Research transparency, reproducibility and accessibility in Allergy, 2003 – 2023: Preliminary results of the TRACES study

Thumbnail

D2.418 - Risk Factors for Severe Allergic Rhinitis and the Association with Serum sIgE Levels: A Study in Guangzhou, China

Thumbnail

D2.430 - Two cases of acquired angioedema: one with splenic lymphoma and the other with Waldenström’s macroglobulinemia

Thumbnail

D2.431 - Association of serum IgE levels and atopic status with cancer in the general population

Thumbnail

D2.433 - AllergoOncology: Immunocompetent 3D and Skin Organoid Models of Melanoma to Investigate Tumour-Immune Interactions and Immunotherapies

Thumbnail

D2.434 - AllergoOncology: Novel crusade for Basophil Activation Test

Thumbnail

D2.432 - Blood morphology in health & cancer: comparative, preliminary study on 783 patients

Thumbnail

D3.389 - Deep Learning-Based Real-Time Identification of Wheezing in Lung Sounds: Applications in Disease Prediction and Early Intervention

Thumbnail

D3.390 - Rationale and Design for ALPHA-ORBIT: a phase 3 trial of navenibart, a monoclonal antibody inhibitor of plasma kallikrein for participants with hereditary angioedema (HAE)

Thumbnail

D3.391 - Results from the ALPHA-STAR Trial, a Phase 1b/2 Single and Multiple Dose Study to Assess the Safety, Tolerability, Clinical Activity, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Navenibart in Participants with Hereditary Angioedema (HAE)

Thumbnail

D3.392 - What information and education is crucial for people with food allergies?

Thumbnail

D3.393 - Daily life with a peanut allergy, as a young adult- an interview study

Thumbnail

D3.394 - Anxiety Associated with Parenteral On-Demand Treatment for Hereditary Angioedema Attacks in Patients from Italy

Thumbnail

D3.395 - Evaluation for suspected penicillin allergy - the patient perspective